Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 4, 2005, Pages 219-224

  Gutt, Bodo ^a,d   Wowra, B ^b   Alexandrov, R ^c   Uhl, E ^a   Schaaf, L ^c   Stalla, G K ^c   Schopohl, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Gamma Knife Center   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acromegaly; Gamma knife surgery; Irradiation

Indexed keywords

GROWTH HORMONE RECEPTOR ANTAGONIST; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; COHORT ANALYSIS; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR VOLUME;

ACROMEGALY; ADENOMA; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RADIOSURGERY; REFERENCE VALUES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 18844447714     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837552     Document Type: Article

References (23)

1. Abe T, Ludecke DK. Recent results of secondary transnasal surgery for residual or recurring acromegaly. Neurosurg 1998; 42: 1013-1021; discussion 1021-1022
2. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003; 88: 3105-3112
3. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 2004; 89: 1613-1617
4. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, Sandler HM. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metabolism 1997; 82: 3187-3191
5. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993; 86: 293-299
6. Beauregard C, Truong U, Hardy J, Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol 2003; 58: 86-91
7. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85: 526-529
8. Gutt B, Hatzack C, Morrison K, Pollinger B, Schopohl J. Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. Eur J Endocrinol 2001; 144: 109-116
9. Hardy J. Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT (eds). Diagnosis and Treatment of Pituitary Tumors. New York: Elsevier Publishing Co. Inc., 1973: 179-194
10. Hayashi M, Izawa M, Hiyama H, Nakamura S, Atsuchi S, Sato H, Nakaya K, Sasaki K, Ochiai T, Kubo O, Hori T, Takakura K. Gamma knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 1999; 72: 111-118
11. Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004; 89: 667-674
12. Kurosaki M, Luedecke DK, Abe T. Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 2003; 50: 635-642
13. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg 1998; 88: 1002-1008
14. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G. Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 2000; 85: 1287-1289
15. Laws ER Jr, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 1999; 10: 327-336
16. Lim YL, Leem W, Kim TS, Rhee BA, Kim GK. Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 1998; 70: 95-109
17. Melmed S. Acromegaly. New Engl J Med 1990; 322: 966-977
18. Merza Z. Modern treatment of acromegaly. Postgrad Med J 2003; 79: 189-194
19. Mokry M, Ramschak-Schwarzer S, Simbrunner J, Ganz JC, Pendl G. A six-year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 1999; 72: 88-100
20. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC. Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir 1998; 140: 437-443
21. Powell JS, Wardlaw SL, Post KD, Freda PU. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 2000; 85: 2068-2071
22. Sheppard MC. Aims of treatment and definition of case. In: Wass JAH (ed). Treating Acromegaly. Bio Scientifica Ltd, Bristol, UK: Society for Endocrinology, 1994: 17-23
23. Thoren M, Rahn T, Guo WY, Werner S. Stereotactic radiosurgery with the cobalt-60 gamma unit in the treatment of growth hormone-producing pituitary tumors. Neurosurg 1991; 29: 663-668